Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) PT at $7.57

Shares of LifeMD, Inc. (NASDAQ:LFMD) have been given an average recommendation of “Moderate Buy” by the ten research firms that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation and eight have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $7.5714.

LFMD has been the subject of several research reports. Lake Street Capital set a $5.00 price objective on shares of LifeMD in a research note on Thursday, August 6th. KeyCorp set a $5.00 target price on LifeMD and gave the company an “overweight” rating in a report on Friday, August 7th. Mizuho set a $7.00 price target on LifeMD in a research report on Thursday, August 6th. B. Riley Financial dropped their price target on LifeMD from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Finally, HC Wainwright dropped their price target on LifeMD from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Friday, August 7th.

Institutional Trading of LifeMD

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Caitong International Asset Management Co. Ltd purchased a new position in LifeMD in the fourth quarter valued at approximately $36,000. R Squared Ltd purchased a new stake in LifeMD during the first quarter worth approximately $41,000. Jain Global LLC purchased a new stake in LifeMD during the fourth quarter worth approximately $45,000. Quarry LP purchased a new stake in LifeMD during the third quarter worth approximately $52,000. Finally, Tower Research Capital LLC TRC increased its position in shares of LifeMD by 110.4% in the second quarter. Tower Research Capital LLC TRC now owns 4,674 shares of the company’s stock worth $64,000 after acquiring an additional 2,452 shares in the last quarter. Institutional investors and hedge funds own 35.52% of the company’s stock.

LifeMD Stock Performance

LFMD opened at $3.45 on Friday. LifeMD has a 1 year low of $2.56 and a 1 year high of $7.32. The company’s 50 day simple moving average is $4.26 and its 200 day simple moving average is $3.97. The stock has a market capitalization of $166.29 million, a PE ratio of -68.99 and a beta of 2.02.

LifeMD (NASDAQ:LFMD) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.01). The company had revenue of $47.28 million for the quarter, compared to analyst estimates of $49.16 million. LifeMD had a negative return on equity of 168.23% and a net margin of 0.10%. As a group, sell-side analysts expect that LifeMD will post -0.48 earnings per share for the current fiscal year.

About LifeMD

LifeMD (NASDAQ: LFMD) is a U.S.-based telehealth company that delivers on-demand, membership-based virtual healthcare services. Through its digital platform and mobile applications, LifeMD connects patients with board-certified healthcare providers for diagnosis, treatment and ongoing management of a range of acute and chronic conditions. The company’s core offering centers on personalized care plans supported by prescription fulfillment, lab testing and prescription delivery services.

LifeMD’s service portfolio spans several specialty areas, including men’s health, hormonal therapy, weight management and primary care.